Table 1.
Comparison of Clinical Characteristics between the EVAC and SEMS Groups Treated for Anastomotic Leakage
| Characteristic | Total (n=39) | EVAC (n=11) | SEMS (n=28) | p-value |
|---|---|---|---|---|
| Age, yr | 66.0 (39–82) | 68.0 (55–81) | 63.5 (39–82) | 0.450 |
| ASA | ||||
| 1 or 2 | 24 (61.5) | 6 (54.5) | 18 (64.3) | 0.718 |
| 3 or 4 | 15 (38.5) | 5 (45.5) | 10 (35.7) | 0.718 |
| Cardiovascular disease | 23 (59.0) | 9 (81.8) | 14 (50.0) | 0.086 |
| Diabetes mellitus | 10 (25.6) | 4 (36.4) | 6 (21.4) | 0.424 |
| Use of anticoagulant or antiplatelet agent | 14 (35.9) | 6 (54.5) | 8 (28.6) | 0.156 |
| Type of surgery | ||||
| Total or proximal gastrectomy | 28 (73.7) | 6 (54.5) | 22 (78.6) | 0.234 |
| Billroth I or II | 11 (28.2) | 5 (45.5) | 6 (21.4) | 0.234 |
| TNM stage | ||||
| 1 or 2 | 27 (69.2) | 9 (81.8) | 18 (64.3) | 0.446 |
| 3 or 4 | 12 (30.8) | 2 (18.2) | 10 (35.7) | 0.446 |
| Preoperative BMI, kg/m2 | 24.5 (21.2–26.4) | 23.8 (19.8–25.4) | 24.6 (22.1–26.5) | 0.363 |
| Size of leak, cm | 1.5 (1.0–2.0) | 2.1 (2.0–3.0) | 1.0 (0.8–1.5) | <0.001 |
Data are presented as median (interquartile range) or number (%).
EVAC, endoscopic vacuum-assisted closure; SEMS, self-expandable metallic stent; ASA, American Society of Anesthesiologists; BMI, body mass index.